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Abstract
Objective: To investigate the association between IL-18 polymorphisms and Tuberculosis(TB).
Materials and methods: We searched PubMed and Embase databases, and conducted a meta-analysis using 4 models. Data 
were extracted from the studies by two independent reviewers. Statistical analysis was performed using STATA 12.0 software. 
Results: Five qualified studies with a total of  1293 TB patients and 1724 controls were included.There was no significant associ-
ation between the IL-18 -607C>A polymorphism and TB risk in the total population(AA vs CC: OR=1.27,95% CI=0.82-1.96;-
CA vs CC:OR=1.06,95% CI=0.89-1.26; Dominant model: OR =1.09, 95% CI =0.83-1.43; Recessive model:OR=1.23, 95% 
CI=0.92-1.65).For IL-18 -137G>C polymorphism, lack of  an association was also found(GG vs CC: OR=1.42,95% CI=0.78-
2.58;GC vs CC:OR=1.16,95% CI=0.62-2.16; Dominant model: OR =1.34,95% CI=0.74-2.43;Recessive model:OR=0.96,95%-
CI=0.26-3.56).
Conclusion: The present meta-analysis found no evidence for IL-18 -607C>A and -137G>C polymorphisms as risk factors for 
TB. Further large-scale and well-designed articles are still needed to validate this result.
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Tuberculosis (TB) is currently among the most important 
global health challenges. A global TB report estimated 
approximately 8.7 million cases worldwide, most are in 
Asia and Africa1. Approximately one-third of  the world’s 
population is thought to be affected by M. tuberculosis, 
however, a relatively large number of  infected individuals 
exhibit no signs of  the disease. Nevertheless, the remain-
ing 10% of  infected individuals develop active disease lat-
er in life2.  As we all know, a series of  factors lead to the 
risk of  infection and disease progression, including mal-
nutrition, smoking, diabetes, alcohol use, socioeconomic 
status and environmental pollution3. Several studies have 
focused on the relationship between genetic variations of  
several genes and susceptibility to TB4,5.
Interleukin-18 (IL-18), first defined as an interferongam-
ma inducing factor (IGIF), is a novel cytokine belonging 
to the IL-1 family and plays a strategic role in inflamma-
tion and immune reactions6. IL-18 is primarily produced 
by macrophages, dendritic cells, keratinocytes, osteoblasts 
and intestinal epithelial cells7. The role of  IL-18 has been 
actively studied in the pathogenesis of  many disease,in-
cluding cancers and digestive diseases8. Evidence from 
previous studies appears to support a significant role of  
IL-18 in TB infection and anti-tuberculosis immunity9.
The IL-18 gene is located on chromosome 11q22.2–q22.3, 
and contains several genetic polymorphisms, especially in 
the promoter region. The variations in IL-18 gene pro-
moter have an impact on the production and activity of  
IL-18. IL-18 gene promoter -607C>A (rs1946518) and 
-137G>C (rs187238) polymorphisms are two of  the most 
common single nucleotide polymorphisms10. Cloning and 
transcriptional analysis showed that these two polymor-
phisms changed the IL-18 expression levels. However, 
studies conducted to examine the potential contributions 
of  IL-18 polymorphisms to TB susceptibility have pro-
duced contradictory results.
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Individual studies based on small sample sizes do not 
have enough statistical power to detect positive associa-
tions, and perhaps more importantly, to prove that there 
is no association.Thus contradictory published results 
may only reflect the low statistical power of  individual 
studies. Therefore, we performed a meta-analysis of  all 
the data published so far to establish statistical evidence 
of  the association between IL-18 polymorphisms and the 
risk of  TB.
 
Materials and methods
Literature search and selection criteria 
Through the search for Embase, Pubmed, Cochrane Li-
brary, the Chinese BiologicalMedical database and the 
Chinese National Knowledge Infrastructure databases, 
the following terms were searched up to January 2018: 
“tuberculosis” OR “TB” in combination with “inter-
leukin” OR “IL” OR “-607C>A” OR “-137G>C” and 
“polymorphism” OR “variant” OR “gene”.References 
of  retrieved articles or/and reviews were also manual-
ly screened to obtain additional relevant eligible studies. 
Data were independently retrieved by 2 investigators (Li-
Bo Zhen and Ya-Ping Sun), and a consensus was reached 
on all items.
 
Criteria for inclusion and exclusion
The inclusion criteria were as follows:(1) case-control 
studies conducted to assess the association between the 
IL-18 gene polymorphism and the risk of  TB;(2)suffi-
cient genotype data presented to calculate the odds ratios 
(ORs) and 95% confidence intervals (CIs); and (3) the 
search was not restricted by language and was conduct-
ed on human subjects. The exclusion criteria were as fol-
lows:(1)abstracts and reviews;(2) genotype frequency not 
reported; and (3) repeat or overlapping publications.
Data extraction
The following data were abstracted from each study: First 
author's name, year of  publication, country of  sample, 
nationality,number of  patients and controls,genotyping 
of  gene polymorphisms,and evidence of  Hardy–Wein-
berg equilibrium (HWE), which are listed in Table 1.
Statistical analysis
For included articles, the HWE of  genotypes in the con-
trols was evaluated using the Pearson chi-squared test.
The strength of  the association between IL-18 polymor-
phisms and TB risk was measured by odds ratios (ORs) 
with 95% confidence intervals (CIs) for homozygote 
comparison (TT versus CC), heterozygote comparison 
(CT versus CC),dominant model(TT+CT versus CC) 
and the recessive model (TT versus CT+CC). The het-
erogeneity among these studies was checked by the I2 
test. I2 > 50% indicated heterogeneity across studies, in 
which case the random effects model was used for me-
ta-analysis, otherwise the fixed effects model was used.
Furthermore,a single study involved in the meta-analysis 
was deleted each time to reflect the influence of  the in-
dividual dataset on the pooled ORs.Publication bias was 
measured using Begg’s test and Egger’s tests. The STA-
TA 12.0 software was performed in our study(Stata Corp, 
College Station, TX, USA) .
Results 
There were 193 related articles in the primary search. 
Screening was carried out exactly according to the inclu-
sion and exclusion criteria. Abstracts as well as the whole 
papers were further read carefully and then 188 litera-
tures were excluded. Finally, 5 case-control studies were 
included11-15. There was a total of  3017 subjects in the 5 
case-control studies, including 1293 TB cases and 1724 
controls. A detailed flowchart of  the research options is 
shown in Figure 1. All the literature were the case-control 
studies of  IL-18 polymorphisms and TB susceptibility in 
Asians. The baseline characteristics of  this meta-analysis 
included in this meta-analysis are summarized in Table 1. 
All included case-control studies were published in En-
glish from 2007 to 2017.
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Table 1.  Study selection and subject characteristics of included studies in meta-analysis. 






            CC   CA   AA CC   CA   AA            
-607C>A                 
Harishankar 2007 India Asian 165 173 75     71       19 85    73      15 0.90 
Han 2011 China Asian 296 680 45     168     83 164  395    121 0.00 
Lee 2011 Korea Asian 251 225 65     113     62 55    116    54 0.64 
Taheri 2012 Iran Asian 174 177 74      80      20 68     90     19 0.18 
Zhou 2015 China Asian 407 469 109    217    81 124   247   98 0.22 
-137G>C           GG   GC   CC GG   GC   CC   
Harishankar 2006 India Asian 165 173 97      51      10 103   56      9 0.70 
Lee 2011 Korea Asian 251 225 188    61      2 173   47      5 0.40 




Figure 1: The flowchart of the included studies in the meta-analysis; 
The main results of  meta-analysis of  IL-18 -607C>A 
polymorphism and TB risk are presented in Table 2.In 
pooled analysis using data from all 5 studies, no significant 
association was found between IL-18 -607C>A polymor-
phism and TB risk(see Figure 2: AA vs CC: OR=1.27,95% 
CI=0.82-1.96;CA vs CC:OR=1.06,95% CI=0.89-1.26; 
Dominant model: OR =1.09, 95% CI =0.83-1.43;Re-
cessive model:OR=1.23, 95% CI=0.92-1.65).To explore 
the sources of  heterogeneity, we performed further sub-
group analyses by omission of  non-HWE studies and the 
heterogeneity were removed, suggesting that the study 
deviating from HWE was the main source of  heteroge-
neity in the meta analysis(Table 2).
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Table 2.  Summary ORs and 95%CI of IL-18 gene polymorphisms and TB risk. 
Subgroup Genetic model Effects  
model 
Test of heterogeneity Test of association 
      I2       P    OR     95% CI 
-607C>A         
Overall AA vs CC Random 70.2%   0.01 1.27    0.82-1.96 
  CA vs CC Fixed 39.7%   0.16 1.06    0.89-1.26 
  Dominant model Random 59.8%   0.04 1.09    0.83-1.43 
  Recessive model Random 52.5%   0.08 1.23    0.92-1.65 
Consistent with AA vs CC Fixed 0.00%   0.80 1.01   0.77-1.31 
HWE CA vs CC Fixed 0.00%   0.72 0.94    0.77-1.15 
  Dominant model Fixed 0.00%   0.72 0.96    0.79-1.16 
  Recessive model Fixed 0.00%   0.80 1.04    0.83-1.31 
-137G>C         
  GG vs CC Fixed 2.00%   0.36 1.42   0.78-2.58 
  GC vs CC Fixed 0.00%   0.38 1.16   0.62-2.16 
  Dominant model Fixed 0.00%   0.38 1.34   0.74-2.43 




Figure 2: Forest plot for meta-analysis of the association between the 
IL-18 -607C>A polymorphism and TB risk; 
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The main results of  meta-analysis of  IL-18 -137G>C 
polymorphism and TB risk are summarized in Ta-
ble 2.The results of  pooling all studies showed that 
the IL-18 -137G>C polymorphism was not associ-
ated with TB susceptibility (see Figure 3: GG vs CC: 
OR=1.42,95% CI=0.78-2.58;GC vs CC:OR=1.16,95% 
CI=0.62-2.16;Dominant model: OR =1.34, 95% CI 




Figure 3: Forest plot formeta-analysis of the association between  
the IL-18 -137G>C polymorphism and TB risk 
Sensitivity analysis was performed via assessment of  the 
influence of  each individual paper on the pooled OR by 
deleting one study at a time. No single article influenced 
the pooled ORs, suggesting that the results were stable 
(Figure 4 and 5). 
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Figure 4: One-way sensitivity analysis of the pooled odds ratios and 95% 
confidence interval for IL-18 -607C>A polymorphism, omitting each dataset in the meta-analysis 
 
 
Figure 5: One-way sensitivity analysis of the pooled odds ratios and 95% 
confidence interval for IL-18 -137G>C polymorphism, omitting each dataset in the meta-analysis 
Begg and Egger’s tests were performed to assess the pub-
lication bias of  included articles(Figure 6-9).The shapes 
of  the funnel plots in all genetic models revealed no evi-
dence of  obvious asymmetry in the allele model, implying 
that publication bias was low in our meta-analysis (all P 
> 0.05).
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Figure 6: Egger’s funnel plot analysis to detect potential publication  





Figure 7: Egger’s funnel plot analysis to detect potential publication  
bias for IL-18 -137G>C polymorphism 
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Figure 9: Begg’s test to detect potential publication bias for IL-18 -137G>C polymorphism. 
Discussion
TB is a global public health problem that remains a huge 
burden throughout the world, although there has been an 
overall decline in TB incidence and mortality to this date. 
Accumulating evidence suggests that inflammatory cyto-
kines  play an important role in the pathogenesis of  TB. 
IL-18, belonging to the IL-1 superfamily, is a pleiotropic 
proinflammatory cytokine, which is involved in the regu-
lation of  both innate and acquired immune responses16.
Concerning the effect of  IL-18 polymorphisms on TB, 
contradictory results have obtained by previous studies. 
In the present study, we used meta-analysis to more accu-
rately assess the impact of  IL-18 SNPs on TB risk. 
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To assess the role of  IL-18 gene polymorphisms in sus-
ceptibility to TB, we conducted a meta-analysis of  5 
case-control studies, involving 1293 TB cases and 1724 
healthy subjects. For the IL-18 -607C>A polymorphism, 
we found no association between this variant and TB 
susceptibility in the total population. Significant be-
tween-study heterogeneity was found among the three 
comparison models.Notably, after removing one article 
that deviated from HWE, the heterogeneity disappeared 
from stratification analysis.In addition, other factors in-
cluding design diversity,sample sizes, and measurement 
errors may lead to heterogeneity. Because of  the lack 
of  relevant data,this factor requires further research in 
the future. For the IL-18 -137G>C polymorphism, no 
association was observed between the IL-18 -137G>C 
polymorphism and the risk of  TB among all the genetic 
models.
Limitations
Some limitations of  this meta-analysis should be acknowl-
edged. First, this meta-analysis was based on a limited 
number of  studies and the relatively small sample size, 
may reduce statistical power, especially for sub-group 
analysis. Second, due to the lack of  detailed information 
such as lacking of  subtyping of  the TB in individual stud-
ies, we could not conduct further sub-group analysis to 
adjust for these possible confounding factors. Third, we 
only chose articles published electronically in two data-
bases, and therefore some pertinent articles not included 
in these databases or unpublished articles with negative 
results may have been missed. Finally, gene-environment 
and gene-gene interactions were not considered in this 
study.
Conclusion
This meta-analysis suggested that there was no associa-
tion between IL-18 polymorphisms and TB risk in the 
overall population. Considering the above-mentioned 
limitations, larger-scale and well-designed articles are re-
quired to further validate these findings and investigate 
an even wider range of  associations in the future.
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